Ryan Zimmerman
Stock Analyst at BTIG
(4.40)
# 260
Out of 4,829 analysts
174
Total ratings
56.08%
Success rate
14.23%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $87 → $91 | $58.78 | +54.81% | 11 | Dec 12, 2024 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $43.35 | +52.25% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $299.10 | -9.73% | 19 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $94.24 | +58.11% | 10 | Nov 26, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $535 → $561 | $556.92 | +0.73% | 17 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $388.23 | +1.49% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $1.28 | +684.31% | 4 | Oct 18, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $94.89 | +11.71% | 11 | Oct 14, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $13.40 | - | 6 | Oct 7, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $134 → $126 | $97.64 | +29.05% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $73.97 | +35.19% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $75.14 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $13.57 | +437.95% | 4 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $20.46 | +159.04% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.51 | +485.37% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.46 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.00 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.31 | +205.13% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.09 | +94.17% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.90 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $23.37 | +122.51% | 7 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.68 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $9.93 | +181.97% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $164.14 | +21.85% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $316.35 | +10.64% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $132.63 | -1.98% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $54.79 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $85.72 | +49.32% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $13.97 | +7.41% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $58.48 | +55.61% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $18.25 | +130.14% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $4.78 | +998.33% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.62 | - | 3 | Apr 2, 2020 |
Globus Medical
Dec 12, 2024
Maintains: Buy
Price Target: $87 → $91
Current: $58.78
Upside: +54.81%
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $43.35
Upside: +52.25%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $299.10
Upside: -9.73%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $94.24
Upside: +58.11%
Intuitive Surgical
Nov 26, 2024
Maintains: Buy
Price Target: $535 → $561
Current: $556.92
Upside: +0.73%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $388.23
Upside: +1.49%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $1.28
Upside: +684.31%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $94.89
Upside: +11.71%
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $13.40
Upside: -
Zimmer Biomet Holdings
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $97.64
Upside: +29.05%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $73.97
Upside: +35.19%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $75.14
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $72 → $73
Current: $13.57
Upside: +437.95%
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $20.46
Upside: +159.04%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.51
Upside: +485.37%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.46
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.00
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $1.31
Upside: +205.13%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $3.09
Upside: +94.17%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $8.90
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $23.37
Upside: +122.51%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $12.68
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $9.93
Upside: +181.97%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $164.14
Upside: +21.85%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $316.35
Upside: +10.64%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $132.63
Upside: -1.98%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $54.79
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $85.72
Upside: +49.32%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $13.97
Upside: +7.41%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $58.48
Upside: +55.61%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $18.25
Upside: +130.14%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $4.78
Upside: +998.33%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $11.62
Upside: -